These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 24772965

  • 1. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.
    Kumudini N, Umai A, Devi YP, Naushad SM, Mridula R, Borgohain R, Kutala VK.
    Indian J Biochem Biophys; 2013 Oct; 50(5):436-41. PubMed ID: 24772965
    [Abstract] [Full Text] [Related]

  • 2. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.
    Białecka M, Droździk M, Kłodowska-Duda G, Honczarenko K, Gawrońska-Szklarz B, Opala G, Stankiewicz J.
    Acta Neurol Scand; 2004 Oct; 110(4):260-6. PubMed ID: 15355491
    [Abstract] [Full Text] [Related]

  • 3. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.
    Torkaman-Boutorabi A, Ali Shahidi G, Choopani S, Reza Zarrindast M.
    Folia Neuropathol; 2012 Oct; 50(4):382-9. PubMed ID: 23319194
    [Abstract] [Full Text] [Related]

  • 4. Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.
    Białecka M, Droździk M, Honczarenko K, Gawrońska-Szklarz B, Stankiewicz J, Dabrowska E, Kubisiak M, Kłodowska-Duda G, Opala G.
    Eur Neurol; 2005 Oct; 53(2):68-73. PubMed ID: 15753616
    [Abstract] [Full Text] [Related]

  • 5. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
    Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, Fukuoka Kinki Parkinson's Disease Study Group.
    BMC Neurol; 2011 Jul 25; 11():89. PubMed ID: 21781348
    [Abstract] [Full Text] [Related]

  • 6. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M.
    Pharmacogenet Genomics; 2008 Sep 25; 18(9):815-21. PubMed ID: 18698234
    [Abstract] [Full Text] [Related]

  • 7. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
    Vallelunga A, Flaibani R, Formento-Dojot P, Biundo R, Facchini S, Antonini A.
    Parkinsonism Relat Disord; 2012 May 25; 18(4):397-9. PubMed ID: 22113132
    [Abstract] [Full Text] [Related]

  • 8. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.
    Zhang Y, Piao X, Wu J, Li Y, Liang Q.
    Int J Neurosci; 2016 May 25; 126(5):400-7. PubMed ID: 26000819
    [Abstract] [Full Text] [Related]

  • 9. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese.
    Wu RM, Cheng CW, Chen KH, Lu SL, Shan DE, Ho YF, Chern HD.
    Neurology; 2001 Feb 13; 56(3):375-82. PubMed ID: 11171904
    [Abstract] [Full Text] [Related]

  • 10. Variability and validity of polymorphism association studies in Parkinson's disease.
    Tan EK, Khajavi M, Thornby JI, Nagamitsu S, Jankovic J, Ashizawa T.
    Neurology; 2000 Aug 22; 55(4):533-8. PubMed ID: 10953187
    [Abstract] [Full Text] [Related]

  • 11. Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes.
    Schellekens AF, Franke B, Ellenbroek B, Cools A, de Jong CA, Buitelaar JK, Verkes RJ.
    Arch Gen Psychiatry; 2012 Apr 22; 69(4):339-48. PubMed ID: 22474103
    [Abstract] [Full Text] [Related]

  • 12. The catechol-O-methyltransferase and monoamine oxidase B polymorphisms and levodopa therapy in the Iranian patients with sporadic Parkinson's disease.
    Torkaman-Boutorabi A, Shahidi GA, Choopani S, Rezvani M, Pourkosary K, Golkar M, Zarrindast MR.
    Acta Neurobiol Exp (Wars); 2012 Apr 22; 72(3):272-82. PubMed ID: 23093014
    [Abstract] [Full Text] [Related]

  • 13. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
    Goudreau JL, Maraganore DM, Farrer MJ, Lesnick TG, Singleton AB, Bower JH, Hardy JA, Rocca WA.
    Mov Disord; 2002 Nov 22; 17(6):1305-11. PubMed ID: 12465073
    [Abstract] [Full Text] [Related]

  • 14. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.
    Bialecka M, Klodowska-Duda G, Honczarenko K, Gawrońska-Szklarz B, Opala G, Safranow K, Droździk M.
    Parkinsonism Relat Disord; 2007 May 22; 13(4):224-9. PubMed ID: 17270484
    [Abstract] [Full Text] [Related]

  • 15. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
    Lafuente A, Bernardo M, Mas S, Crescenti A, Aparici M, Gasso P, Deulofeu R, Mane A, Catalan R, Carne X.
    Psychiatry Res; 2008 Nov 30; 161(2):131-41. PubMed ID: 18922583
    [Abstract] [Full Text] [Related]

  • 16. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.
    McGregor NW, Hemmings SMJ, Erdman L, Calmarza-Font I, Stein DJ, Lochner C.
    Psychiatry Res; 2016 Dec 30; 246():527-532. PubMed ID: 27821364
    [Abstract] [Full Text] [Related]

  • 17. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M, Mihaljević-Peles A, Bozina N, Sagud M, Nikolac-Perkovic M, Vuksan-Cusa B, Muck-Seler D.
    J Clin Psychopharmacol; 2013 Oct 30; 33(5):593-9. PubMed ID: 23963056
    [Abstract] [Full Text] [Related]

  • 18. Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.
    Gupta M, Chauhan C, Bhatnagar P, Gupta S, Grover S, Singh PK, Purushottam M, Mukherjee O, Jain S, Brahmachari SK, Kukreti R.
    Pharmacogenomics; 2009 Feb 30; 10(2):277-91. PubMed ID: 19207030
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele.
    Planté-Bordeneuve V, Taussig D, Thomas F, Said G, Wood NW, Marsden CD, Harding AE.
    Neurology; 1997 Jun 30; 48(6):1589-93. PubMed ID: 9191771
    [Abstract] [Full Text] [Related]

  • 20. Impact of COMT Val 108/158 Met and DRD2 Taq1B gene polymorphisms on vulnerability to cigarette smoking of Thai males.
    Suriyaprom K, Tungtrongchitr R, Harnroongroj T.
    J Mol Neurosci; 2013 Mar 30; 49(3):544-9. PubMed ID: 22740151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.